CN111826471A - N-DHCLV real-time fluorescent quantitative PCR detection primer and kit - Google Patents
N-DHCLV real-time fluorescent quantitative PCR detection primer and kit Download PDFInfo
- Publication number
- CN111826471A CN111826471A CN202010883750.3A CN202010883750A CN111826471A CN 111826471 A CN111826471 A CN 111826471A CN 202010883750 A CN202010883750 A CN 202010883750A CN 111826471 A CN111826471 A CN 111826471A
- Authority
- CN
- China
- Prior art keywords
- dhclv
- real
- quantitative pcr
- fluorescent quantitative
- time fluorescent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000003753 real-time PCR Methods 0.000 title claims abstract description 38
- 238000001514 detection method Methods 0.000 title claims abstract description 36
- 239000000523 sample Substances 0.000 claims abstract description 40
- 125000006853 reporter group Chemical group 0.000 claims description 8
- 238000011144 upstream manufacturing Methods 0.000 claims description 6
- 238000010791 quenching Methods 0.000 claims description 5
- 230000000171 quenching effect Effects 0.000 claims description 5
- 238000000034 method Methods 0.000 abstract description 20
- 238000003752 polymerase chain reaction Methods 0.000 abstract description 16
- 239000013612 plasmid Substances 0.000 abstract description 10
- 230000003321 amplification Effects 0.000 abstract description 5
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 5
- 230000035945 sensitivity Effects 0.000 abstract description 5
- 208000015181 infectious disease Diseases 0.000 abstract description 3
- FMGSKLZLMKYGDP-UHFFFAOYSA-N Dehydroepiandrosterone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CC=C21 FMGSKLZLMKYGDP-UHFFFAOYSA-N 0.000 abstract description 2
- 238000010276 construction Methods 0.000 abstract description 2
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 abstract description 2
- 238000013461 design Methods 0.000 abstract description 2
- 229960002847 prasterone Drugs 0.000 abstract description 2
- 238000005457 optimization Methods 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 16
- 241000700605 Viruses Species 0.000 description 11
- 241000272525 Anas platyrhynchos Species 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 7
- 241001664991 Duck circovirus Species 0.000 description 5
- 241000711549 Hepacivirus C Species 0.000 description 5
- 241001300257 Muscovy duck reovirus Species 0.000 description 5
- 241001557656 Duck hepatitis A virus 1 Species 0.000 description 4
- 241001557661 Duck hepatitis A virus 3 Species 0.000 description 4
- 241000710781 Flaviviridae Species 0.000 description 4
- 241001503699 Muscovy duck parvovirus Species 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000007850 fluorescent dye Substances 0.000 description 4
- SYHGEUNFJIGTRX-UHFFFAOYSA-N methylenedioxypyrovalerone Chemical compound C=1C=C2OCOC2=CC=1C(=O)C(CCC)N1CCCC1 SYHGEUNFJIGTRX-UHFFFAOYSA-N 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000711557 Hepacivirus Species 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000012257 pre-denaturation Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000271566 Aves Species 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000710831 Flavivirus Species 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 241000710778 Pestivirus Species 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000007430 reference method Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 241001447918 Baoris Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 241000684283 Duck parvovirus Species 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108010076039 Polyproteins Proteins 0.000 description 1
- 241000338155 Tamana bat virus Species 0.000 description 1
- 241000907504 Tembusu virus Species 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000011841 epidemiological investigation Methods 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000017448 oviposition Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
- C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention relates to a primer and a kit for detecting N-DHCLV (dehydroepiandrosterone-binding-polymerase chain reaction) real-time fluorescent quantitative PCR (polymerase chain reaction), belonging to the field of zooepidemics. The invention comprises the design of specific primers and probe sequences, the construction of standard plasmids, the establishment and optimization of a real-time fluorescent quantitative PCR amplification method and the detection and judgment of results. The real-time fluorescent quantitative PCR method for detecting N-DHCLV, which is established by using the primers and the probe, has the advantages of high sensitivity, good stability, strong specificity and good repeatability in the detection of N-DHCLV, can detect 55.93 copies at least, and can be used for detecting the infection of the N-DHCLV in a clinical sample.
Description
Technical Field
The invention relates to a primer and a kit for detecting N-DHCLV (dehydroepiandrosterone-binding-polymerase chain reaction) real-time fluorescent quantitative PCR (polymerase chain reaction), belonging to the field of zooepidemics.
Background
Real-time fluorescent quantitative PCR is a method of measuring the total amount of products after each Polymerase Chain Reaction (PCR) cycle in DNA amplification reaction using fluorescent chemicals. A method for quantitatively analyzing a specific DNA sequence in a sample to be detected by an internal reference method or an external reference method. The real-time fluorescence quantitative PCR is to detect the PCR process in real time through a fluorescence signal in the PCR amplification process. Since in the exponential phase of PCR amplification, there is a linear relationship between the Ct value of the template and the initial copy number of the template. The fluorescent probe method is to use a sequence-specific fluorescent labeled probe to detect a product, and the appearance of the probe method greatly improves the specificity of a quantitative PCR technology compared with the conventional PCR technology. TaqMan probes, FRET hybridization probes (fluorescence resonance energy transfer probes) and molecular beacons (molecular Beacon) are currently more commonly mentioned. The TaqMan probe method is characterized in that a pair of primers is added in PCR amplification, a specific fluorescent probe is added simultaneously, the probe is specifically combined with a template, and the combination site of the probe is between the two primers. The 5 'end of the probe is marked with a fluorescence Reporter group (R), such as FAM, VIC, JOE and the like, and the 3' end is marked with a fluorescence quenching group (Quencher, Q), such as Eclipse, TAMRA, BHQ1 and the like. When the probe is complete, the fluorescence excited by the 5 'end reporter group through the light source of the instrument is just quenched by the near-distance 3' end fluorophore group, and the instrument can not detect the fluorescence signal excited by the 5 'end reporter group (namely, the emission wavelength of the 5' fluorophore group is just the absorption wavelength of the 3 'fluorophore group, so that the energy is absorbed and transferred to the 3' fluorophore group to emit other fluorescence). Along with the PCR, when the Taq enzyme encounters a probe combined with a template in the chain extension process, the 5 ' -3 ' exonuclease activity (the activity is double-strand specificity, and a free single-strand probe is not influenced) of the Taq enzyme can cut the probe, a 5 ' end reporter group is released to be free in a reaction system, the shielding of a 3 ' end fluorescence quenching group is kept away, and a fluorescence signal emitted by the excited 5 ' end reporter group can be detected by the probe. That is, for each amplified DNA strand, a fluorescent molecule is formed, so that the accumulation of the fluorescent signal and the formation of the PCR product are completely synchronized, and the intensity of the report signal represents the copy number of the template DNA.
Flaviviridae family (Flaviviridae Family) Is a family of small enveloped viruses with single positive stranded RNA genomes, most of which infect mammals and birds, and many of which are host-specific and pathogenic. Phylogenetic relationships based on the amino acid sequence of the conserved domain of RdRP indicate that members of the Flaviviridae group are clustered in 4 currently designated genera of viruses: (Flaviviridae genusFlavivirus genus) Pestiviruses (b) and (b)Pestivirus genus) Hepatitis C virus genus (A), (B)Hepacivirus genus) Pergivirus genus (A), (B), (CPegivirus genus). Wherein, Tamanna bat virus (b)Tamana bat virus) Assigned to a separate branch, was tentatively listed as a potential member of the flaviviruses (flaviviruses). In recent years, with the widespread use of high-throughput sequencing and serological methods, many researchers have found a variety of novel HCV homologous viruses (HCV-like viruses) in different mammals. A novel duck-derived hepatitis C-like virus (N-DHCLV) (Chu L, et al. A highlyvariant hepatitis-like virus in domesticducks. J Gen virol.2019, 100(8):1234-1240. doi: 10.1099/jgv.0.001298) is a newly discovered HCV-like virus (HCV-like virus) that has been discovered in recent years from the egg-laying genetic duck population. The genomics research shows that the genome is single-strand positive-strand RNA, the length of the genome is 11422bp, an Open Reading Frame (ORF) with the length of 10824bp is coded, and the length of the coded polyprotein is 3607 amino acids. Genetic evolutionary analysis shows that the virus belongs to the members of the hepatitis C virus-like genus.
At present, no primer, probe and method related research report for real-time fluorescent quantitative PCR detection of N-DHCLV is found at home and abroad, and the establishment of the invention can fill the blank of related fields at home and abroad.
Disclosure of Invention
The invention aims to fill the blank of the related research report of the existing method for detecting the primer and the probe of the N-DHCLV by the real-time fluorescent quantitative PCR, and provides the primer and the probe for the real-time fluorescent quantitative PCR detection of the N-DHCLV and the using method thereof. The method has the advantages of high sensitivity, good stability, strong specificity and good repeatability, can detect 39.04 copies at least, can be used for molecular epidemiological investigation of N-DHCLV in clinical samples, and provides a detection method and means for determining the molecular epidemiological characteristics of the N-DHCLV.
In order to realize the purpose, the following technical scheme is adopted:
a primer and a probe for real-time fluorescent quantitative PCR detection of N-DHCLV are disclosed, wherein the primer sequence is as follows:
the upstream primer N-DHCLV-T-F: 5'-TGACCCAAACACCAACTTCG-3' the flow of the air in the air conditioner,
the downstream primer N-DHCLV-T-R: 5'-TTCAGTCGCTTCCAATCCAG-3', respectively;
the probe N-DHCLV-T-P is as follows: 5'-AGTCAGAAAATTGTCCCGAGCAGGC-3', wherein the 5 '-end is marked with a fluorescence reporter group FAM, and the 3' -end is marked with a fluorescence quenching group Eclipse.
An N-DHCLV real-time fluorescence quantitative PCR detection kit comprises the primer and the probe.
The established real-time fluorescence quantitative PCR detection method of the N-DHCLV has a reaction system of 20 mul: premix Ex Taq (Probe qPCR) mixture 10. mu.L, each of upstream and downstream primers (N-DHCLV-T-F, N-DHCLV-T-R) (10. mu. mol/L) 0.2. mu.L, Probe (N-DHCLV-T-P) (5. mu. mol/L) 0.5. mu.L, template 1. mu.L, and water to a final volume of 20. mu.L.
The reaction conditions are as follows: pre-denaturation at 95 ℃ for 40 s; 95 ℃ for 5s, 60 ℃ for 25 s, 40 cycles.
Advantageous effects
The invention adopts the primer and the probe for the real-time fluorescent quantitative PCR detection of the N-DHCLV to carry out the detection of the N-DHCLV, and has the following advantages and effects:
1. the detection is rapid and efficient: the detection method does not need to carry out conventional agarose gel electrophoresis detection, and the result can be judged by a program carried by a real-time fluorescent quantitative PCR machine after the reaction is finished. The nucleic acid extraction and result judgment only need 100min, and 96 sample detections can be simultaneously carried out at one time.
2. The quantification is accurate: by preparing a standard substance and drawing a standard curve, the infection of the N-DHCLV is directly and accurately quantified according to the Ct value of the N-DHCLV in the sample to be detected.
3. The sensitivity is high: the lowest detectable 55.93 copies/. mu.L.
4. The specificity is strong: the detection of common infectious diseases (such as H9-AIV, DuCV, MDPV, DHAV-1, DHAV-3, ATmV and MDRV) in the duck group has no response signal, and only the detection of N-DHCLV has a fluorescence signal.
5. The repeatability is good: the intra-group variation coefficient of the established real-time fluorescent quantitative PCR detection method for N-DHCLV detection is 0.69-1.62%, and the inter-group variation coefficient is 0.93-2.41%, which indicates that the established real-time fluorescent quantitative PCR detection method has good repeatability.
Drawings
FIG. 1 amplification curves for real-time fluorescent quantitative PCR, wherein: 1-5: different series of concentrations 5.593X 105—5.593×101Copies/. mu.L template.
FIG. 2 standard curve for real-time fluorescent quantitative PCR.
FIG. 3 sensitivity detection of real-time fluorescent quantitative PCR, in which 1-4: different series of concentrations 5.593X 103-5.593×100Copy/. mu.L template; 5: and (5) negative control.
FIG. 4 specific detection of real-time fluorescent quantitative PCR, wherein: 1: N-DHCLV; c: the test controls (H9-AIV, DuCV, MDPV, DHAV-1, DHAV-3, ATmV, and MDRV) were not effectively distinguished by the naked eye due to the absence of fluorescent signals.
Detailed Description
The following examples further illustrate the invention.
Example 1
1. Relevant test pathogens
The pathogenic novel duck-origin hepatitis C-like virus (N-DHCLV), duck-origin H9 subtype avian influenza virus (H9-AIV), duck circovirus (DuCV), duck parvovirus (MDPV), duck hepatitis virus types 1 and 3 (DHAV-1, DHAV-3), avian tembusu virus (ATmV) and Muscovy Duck Reovirus (MDRV) for the test are identified and stored by the animal veterinary institute of agricultural academy of sciences of Fujian province.
2. Design and Synthesis of primers and probes
Specific primers (N-DHCLV-T-F and N-DHCLV-T-R) and a probe (N-DHCLV-T-P) of a PCR method for real-time fluorescent quantitative detection of N-DHCLV are designed by referring to the gene sequence characteristics of a novel duck-derived hepatitis C virus (N-DHCLV) and combining the genome characteristics of other hepatitis C virus members, wherein the primers are as follows:
the upstream primer N-DHCLV-T-F: 5'-TGACCCAAACACCAACTTCG-3' the flow of the air in the air conditioner,
the downstream primer N-DHCLV-T-R: 5'-TTCAGTCGCTTCCAATCCAG-3', respectively;
the probe N-DHCLV-T-P is as follows: 5'-AGTCAGAAAATTGTCCCGAGCAGGC-3' the flow of the air in the air conditioner,
the 5 '-end of the fluorescent probe is marked with a fluorescent reporter group FAM, and the 3' -end of the fluorescent probe is marked with a fluorescent quenching group Eclipse.
Primers and probes were synthesized by Baori physician technology (Beijing) Inc.
3. Construction of standard substance of real-time fluorescent quantitative PCR method
According to the sequence characteristics of N-DHCLV (FJ 614 strain) and novel duck-origin hepatitis C virus (N-DHCLV) gene (GenBank accession number MK 737639) in GenBank identified in the early stage of the team, a specific primer is designed by using primer design software Oligo (version v7.37), and the sequence of the primer is as follows: N-DHCLV-F3: 5'-ACCCTGTTTCTGAAGCGAACGT-3' and N-DHCLV-R3: 5'-TCCAGGAACAATTGAAAGGTGT-3', used for amplifying a gene fragment of about 791bp, and the primers were synthesized by Baozi physician's technology (Beijing) Co., Ltd.
Extracting N-DHCLV (FJ 614 strain) nucleic acid RNA by using a virus nucleic acid extraction Kit EasyPure Viral DNA/RNA Kit, removing a first strand of genomic cDNA by using a FastKing one-step method, synthesizing a premixed reagent, carrying out reverse transcription to obtain cDNA, carrying out PCR reaction according to a 2 XTransTaq-T PCR SuperMix (+ dye) instruction, preparing a reaction system by referring to the instruction of the Kit, wherein the reaction system is 50 mu L, 25 mu L of 2 XTransTaq-T PCR SuperMix reaction liquid, 1 mu L of upstream/downstream primers (N-DHCLV-F3 and N-DHCLV-R3, 10 mu M) are respectively used, and the prepared nucleic acid cDNA is 1 mu L, and sterilizing deionized water is supplemented until the final volume is 50 mu L. The reaction conditions are as follows: pre-denaturation at 94 ℃ for 4 min; 94 ℃ for 50 s, 54 ℃ for 30 s, 72 ℃ for 60 s, 30 cycles; after the circulation is finished, the extension is carried out for 10 min at 72 ℃. And identifying the PCR product by using 1.5% agarose gel electrophoresis, and cutting and recovering the specific target fragment by using an agarose gel recovery kit.
The RT-PCR amplified specific polymerase 1b protein gene fragment was cloned on pEASY-T1 Cloning vector according to pEASY-T1 Simple Cloning Kit instructions, 8 single colonies were randomly picked up and cultured in ampicillin (content 100. mu.g/mL) resistant LB liquid medium for 14 h, and then the corresponding plasmid was extracted using fast plasmid mini-extraction Kit. The extracted plasmids are subjected to PCR identification by using primers (N-DHCLV-F3 and N-DHCLV-R3) and conditions during PCR amplification, and the screened positive recombinant plasmids are sent to a doctor-Biotech (Beijing) Limited company for sequencing. And carrying out BLAST analysis verification on the sequencing result on NCBI, wherein the positive recombinant plasmid which is in line with the experimental expectation is used as a positive standard (T-N-DHCLV-T) of the real-time fluorescent quantitative PCR, and the nucleotide homology of the positive recombinant plasmid (the plasmid T-N-DHCLV-T) and the nucleotide homology of the novel duck-origin hepatitis C virus (GenBank accession number MK 737639) are 99.8%.
Measuring the concentration of positive standard (T-N-DHCLV-T) with micro nucleic acid analyzer, and calculating its copy number to be 5.593 × 108Copies/. mu.L, were serially diluted 10-fold and the plasmid contents were 5.593X 10, respectively7~5.593×100Copying/microliter, subpackaging and storing at-20 ℃ for later use.
4. Real-time fluorescent quantitative PCR reaction condition
Taking an N-DHCLV positive standard (T-N-DHCLV-T) as a template, and carrying out real-time fluorescence quantitative PCR reaction at different annealing temperatures (54-64 ℃) and under the concentration (2.5-20 mu mol/L) of a primer (N-DHCLV-T-F, N-DHCLV-T-R) and the concentration (1.25-10 mu mol/L) of a probe (N-DHCLV-T-P), so as to optimize the reaction conditions. And (5) judging the result, namely observing amplification of a positive fluorescence signal related to the FAM signal, and judging that the sample to be detected is positive for N-DHCLV infection if the positive fluorescence signal exists.
The optimal reaction system 20 mul optimized by the established real-time fluorescence quantitative PCR detection method of the N-DHCLV is as follows: PremixEx Taq (Probe qPCR) mixture 10. mu.L, each of upstream and downstream primers (N-DHCLV-T-F, N-DHCLV-T-R) (10. mu. mol/L) 0.2. mu.L, Probe (N-DHCLV-T-P) (5. mu. mol/L) 0.5. mu.L, template 1. mu.L, and water were added to a final volume of 20. mu.L.
The optimized optimal reaction conditions are as follows: pre-denaturation at 95 ℃ for 40 s; 95 ℃ for 5s, 60 ℃ for 25 s, 40 cycles.
Using optimized reaction conditions at 5.593X 105—5.593×101Copy/. mu.L was used as template to obtain an amplification kinetics curve (see FIG. 1).
The normal logarithm (lgC) of the plasmid content (C) in each standard substance is taken as an abscissa, the cycle number threshold (Ct value) is taken as an ordinate, and an N-DHCLV real-time fluorescence quantitative PCR standard curve (shown in figure 2) is obtained, wherein the slope of the obtained standard curve is-3.564, the Y-axis intercept is 40.06, the correlation coefficient is 1.000, and the amplification efficiency is 0.91, so that the experimental expectation is met.
5. Sensitivity detection
Using optimized reaction conditions at 5.593X 103—5.593×100Copy/. mu.L is used as template to obtain the lowest detection limit of real-time fluorescence quantitative PCR. As can be seen from FIG. 3, the lowest detection limit of the established real-time fluorescent quantitative PCR method is 5.593X 101Copies/. mu.L (i.e., 55.93 copies/. mu.L).
6. Specificity detection
No response signal was detected for common infectious diseases in duck group (such as H9-AIV, DuCV, MDPV, DHAV-1, DHAV-3, ATmV and MDRV), and only fluorescence signal appeared for N-DHCLV detection (FIG. 4).
7. Repeatability test
The intra-group variation coefficient of the established real-time fluorescent quantitative PCR detection method for N-DHCLV detection is 0.69-1.62%, and the inter-group variation coefficient is 0.93-2.41%, which indicates that the established real-time fluorescent quantitative PCR detection method has good repeatability.
TABLE 1 determination of coefficient of variation for real-time fluorescent quantitative PCR method
8. Clinical application
After 65 clinically collected duck disease materials are detected by using the established N-DHCLV real-time fluorescent quantitative PCR detection method, 5 parts of N-DHCLV is detected to be infected positively, and the copy numbers are 3.503 multiplied by 10 respectively2Copy/. mu.L, 4.332X 103Copy/. mu.L, 9.413X 103Copies/. mu.L and 8.003X 103Copy/. mu.L, positive rate is 7.69%.
The above description is only a preferred embodiment of the present invention, and all equivalent changes and modifications made in accordance with the claims of the present invention should be covered by the present invention.
SEQUENCE LISTING
<110> animal husbandry and veterinary institute of agricultural academy of sciences of Fujian province
<120> N-DHCLV real-time fluorescence quantitative PCR detection primer and kit
<130>5
<160>5
<170>PatentIn version 3.3
<210>1
<211>20
<212>DNA
<213> Artificial sequence
<400>1
<210>2
<211>20
<212>DNA
<213> Artificial sequence
<400>2
<210>3
<211>25
<212>DNA
<213> Artificial sequence
<400>3
agtcagaaaa ttgtcccgag caggc 25
<210>4
<211>22
<212>DNA
<213> Artificial sequence
<400>4
accctgtttc tgaagcgaac gt 22
<210>5
<211>22
<212>DNA
<213> Artificial sequence
<400>5
tccaggaaca attgaaaggt gt 22
Claims (2)
1. A primer and a probe for real-time fluorescent quantitative PCR detection of N-DHCLV are characterized in that: the primer sequences are as follows:
the upstream primer N-DHCLV-T-F: 5'-TGACCCAAACACCAACTTCG-3' the flow of the air in the air conditioner,
the downstream primer N-DHCLV-T-R: 5'-TTCAGTCGCTTCCAATCCAG-3', respectively;
the probe N-DHCLV-T-P is as follows: 5'-AGTCAGAAAATTGTCCCGAGCAGGC-3', wherein the 5 '-end is marked with a fluorescence reporter group FAM, and the 3' -end is marked with a fluorescence quenching group Eclipse.
2. An N-DHCLV real-time fluorescent quantitative PCR detection kit is characterized in that: the kit comprises the primer and the probe of claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010883750.3A CN111826471A (en) | 2020-08-28 | 2020-08-28 | N-DHCLV real-time fluorescent quantitative PCR detection primer and kit |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010883750.3A CN111826471A (en) | 2020-08-28 | 2020-08-28 | N-DHCLV real-time fluorescent quantitative PCR detection primer and kit |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111826471A true CN111826471A (en) | 2020-10-27 |
Family
ID=72917959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010883750.3A Pending CN111826471A (en) | 2020-08-28 | 2020-08-28 | N-DHCLV real-time fluorescent quantitative PCR detection primer and kit |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111826471A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106868226A (en) * | 2017-04-28 | 2017-06-20 | 福建省农业科学院畜牧兽医研究所 | A kind of primer and probe of the detection of duck New-type adenovirus real-time fluorescence quantitative PCR |
CN107299155A (en) * | 2017-08-18 | 2017-10-27 | 福建省农业科学院畜牧兽医研究所 | A kind of primer and probe of goose astrovirus real-time fluorescence quantitative PCR detection |
CN109576399A (en) * | 2019-01-12 | 2019-04-05 | 福建省农业科学院畜牧兽医研究所 | 2 type hepatitis A virus real-time fluorescence quantitative PCR detection primer of duck and probe |
-
2020
- 2020-08-28 CN CN202010883750.3A patent/CN111826471A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106868226A (en) * | 2017-04-28 | 2017-06-20 | 福建省农业科学院畜牧兽医研究所 | A kind of primer and probe of the detection of duck New-type adenovirus real-time fluorescence quantitative PCR |
CN107299155A (en) * | 2017-08-18 | 2017-10-27 | 福建省农业科学院畜牧兽医研究所 | A kind of primer and probe of goose astrovirus real-time fluorescence quantitative PCR detection |
CN109576399A (en) * | 2019-01-12 | 2019-04-05 | 福建省农业科学院畜牧兽医研究所 | 2 type hepatitis A virus real-time fluorescence quantitative PCR detection primer of duck and probe |
Non-Patent Citations (4)
Title |
---|
LILI CHU等: "A highly divergent hepacivirus-like flavivirus in domestic ducks", 《JOURNAL OF GENERAL VIROLOGY》 * |
QINFENG LIAO等: "Genomic characterization of a novel picornavirus in Pekin ducks", 《VETERINARY MICROBIOLOGY》 * |
李自刚等: "《生物检测技术》", 31 August 2016, 中国轻工业出版社 * |
赵伟等: "Ⅰ型鸭肝炎病毒内部核糖体进入位点的结构与功能研究", 《中国预防兽医学报》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107299155B (en) | Primer and probe for real-time fluorescence quantitative PCR detection of goose astrovirus | |
CN107043831B (en) | Duck adenovirus type A and type 2 Real time PCR detection primer, probe and kit | |
CN107385111B (en) | Real-time fluorescent quantitative PCR (polymerase chain reaction) detection primer of goose astrovirus and kit thereof | |
CN110760620A (en) | Classical swine fever virus and African classical swine fever virus dual-fluorescence PCR detection reagent, kit and detection method | |
CN109136410B (en) | LAMP (loop-mediated isothermal amplification) detection primer group, kit and detection method for feline panleukopenia virus | |
CN111304371B (en) | Locked nucleic acid probe fluorescent quantitative PCR detection composition, detection method and detection kit for African swine fever virus wild strain | |
CN115044710B (en) | Primer group and kit for detecting pangolin beta coronavirus and application of primer group and kit | |
CN112522444A (en) | Composition for African swine fever virus LAMP-CRISPR detection, detection kit and detection method | |
CN113564280A (en) | RAA primer for detecting 12 serotypes of avian adenovirus group I and detection method thereof | |
CN107604101B (en) | Novel pigeon adenovirus real-time fluorescent quantitative PCR detection kit | |
CN107586889B (en) | Real-time fluorescent quantitative PCR (polymerase chain reaction) detection primer for pigeon adenovirus EvaGreen | |
CN113046481B (en) | Primer, probe and kit for quantitative fluorescence detection of pigeon adenovirus B | |
CN113046482B (en) | Pigeon adenovirus B-type loop-mediated isothermal amplification detection primer set and kit | |
CN111893218B (en) | Primer and probe for real-time fluorescent quantitative PCR detection of duck hepatitis C virus | |
CN111763774B (en) | Primer group and probe group for dual real-time fluorescent quantitative PCR detection of DuHCV and DuMV | |
CN105296668B (en) | Primer, probe and kit for specifically detecting type 3 ungulate bocavirus parvovirus | |
Liu et al. | Development of reverse transcription loop-mediated isothermal amplification for rapid detection of Batai virus in cattle and mosquitoes | |
CN111826471A (en) | N-DHCLV real-time fluorescent quantitative PCR detection primer and kit | |
CN108707695A (en) | A kind of parrot young bird disease virus real-time fluorescence quantitative PCR detection kit | |
CN114395643A (en) | Double-channel digital PCR detection kit and method for African swine fever virus | |
CN107604102B (en) | Double Real time PCR detection kit for pigeon TTV and novel pigeon adenovirus | |
CN111961758B (en) | N-DMV and N-DHCLV dual real-time fluorescent quantitative PCR identification and detection primer and kit | |
CN111748652A (en) | Primer and probe for double real-time fluorescent quantitative PCR detection of duck circovirus type 1 and duck circovirus type 2 | |
CN111961759A (en) | N-DMV real-time fluorescent quantitative PCR detection primer, probe and kit | |
CN112646933A (en) | Real-time fluorescent quantitative PCR (polymerase chain reaction) detection primer, probe and kit for duck type 4 adenovirus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201027 |
|
RJ01 | Rejection of invention patent application after publication |